On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
On May 31, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a new Early Translational…
On May 18, 2018, The Barbara Ann Karmanos Cancer Institute announced it will expand its Lawrence and Idell…
May 4, 2018, scientists from the National Cancer Institute (NCI) reported that an analysis of a prevention clinical…
On Mar. 9, 2018, Seattle Genetics announced it had completed its acquisition of Cascadian Therapeutics for approximately $614…
On Mar. 6, 2018, the U.S. Food and Drug Administration authorized 23andMe’s Personal Genome Service Genetic Health Risk…
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
On Aug. 16, 2017, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 60 new academic research,…
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…
On May 10, 2017, Siteman Cancer Center met the standards of the American Society for Radiation Oncology (ASTRO)…